Memorial Sloan Kettering Cancer Center (MSK) is proud to announce Jason Lewis, PhD, has been elected as a Fellow of the National Academy of Inventors (NAI), a prestigious honor recognizing individuals who have demonstrated innovation and made tangible contributions to the advancement of technology and society. The NAI recognizes Lewis for his inventions that underpin the development of novel radiopharmaceuticals, nanoparticle drug delivery systems, and antibody-based diagnostics, helping drive forward personalized medicine and targeted therapies.
At MSK, Dr. Lewis is the Emily Tow Chair in Oncology; Deputy Director, Sloan Kettering Institute, Office of Science Education and Training (OSET); and Scientific Director of the Radiochemistry and Molecular Imaging Probe Core Facility. Within The Jason Lewis Lab, Dr. Lewis and researchers focus on creating radiopharmaceuticals for precise cancer diagnosis and treatment. The approach combines small-and-biomolecule-based targeting agents with positron-emitting or therapeutic radioisotopes to enable noninvasive imaging and targeted radiopharmaceutical therapy. The group’s research emphasizes molecular imaging using nonstandard nuclides and aims to develop these agents for clinical applications.
NAI Fellowship is considered the highest professional distinction awarded solely to inventors. This year’s NAI cohort includes 169 U.S. academic and institutional inventors and 16 International Fellows, representing 127 universities, government agencies and research institutions across 40 states. Collectively, the 2025 Fellows hold more than 5,300 U.S. patents and include Noble Prize recipients, National Medal of Science and Technology honorees and members of the National Academy of Sciences, Engineering and Medicine.
Jason Lewis and NAI Fellows will be honored at the NAI 15th Annual Conference in Los Angeles in June 2026.